IL-2 Suppression by Endocannabinoid Activation of PPARgamma

内源性大麻素激活 PPARgamma 抑制 IL-2

基本信息

  • 批准号:
    7254283
  • 负责人:
  • 金额:
    $ 29.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall goal of this 5 year research plan is to elucidate the molecular mechanism responsible for the modulation of T cell function and interleukin-2 (IL-2) deregulation by the structurally-related endocannabinoids, anandamide (AEA) and 2-arachidonyl glycerol (2-AG). Presently, the teleological role of the endocannabinoid system is unknown but there is a growing body of evidence suggesting that it may significantly contribute to the maintenance of immunologic homeostasis. Numerous studies have demonstrated profound effects on biological systems by AEA and 2-AG, with the immune system representing one of the most extensively characterized. The significance of the current proposed studies is that they will provide direct mechanistic insight into the molecular mechanism by which endocannabinoids modulate T cell function, specifically IL-2 regulation. Novel preliminary results are presented demonstrating that IL-2 suppression by both AEA and 2-AG are dependent on COX-2 metabolism leading to the activation of the nuclear receptor, peroxisome proliferator activated receptor gamma (PPARgamma), independently of CB1 and CB2. Additional results are present suggesting that the specific mechanism involves the disruption of the nuclear factor of activated T cells (NFAT) by PPARgamma activation. Based on the observations described above and other preliminary data presented in the proposal, our present investigation will test the hypothesis: Suppression of IL-2 by the endocannabinoids, AEA and 2-AG, is mediated through disruption of NFAT regulation by two distinct cannabinoid receptor-independent mechanisms: (a) altered intracellular calcium regulation; and (b) activation of PPARgamma following COX-2-mediated conversion of AEA and 2-AG into PPARgamma agonists. We will test our hypothesis using the following specific aims (SA): SA1 is to characterize the role altered intracellular calcium regulation by AEA and 2-AG plays in deregulation of NFAT and, consequently, suppression of IL-2 gene expression; SA2 is to characterize the role of COX-2 on the deregulation of NFAT and suppression of IL-2 by AEA and 2-AG; SA3 is to characterize the role of PPARgamma activation by AEA and 2-AG treatment in altered NFAT regulation and suppression of IL-2; and SA4 is to identify and characterize the bioactive forms of AEA and 2-AG responsible for PPARgamma activation and to elucidate its contribution to IL- 2 suppression.
描述(由申请人提供):该5年研究计划的总体目标是阐明负责调节T细胞功能和白介素-2(IL-2)的分子机制,结构相关的内源于anandamiDes(AEA)(AEA)(AEA)(AEA) )和2-芳烃甘油(2-ag)。目前,内源性大麻素系统的目的论作用尚不清楚,但是越来越多的证据表明,它可能会显着促进免疫稳态的维持。大量研究表明,AEA和2-AG对生物系统的影响很大,其免疫系统代表了最广泛的特征之一。当前提出的研究的意义在于,它们将直接对内源性大麻素调节T细胞功能,特别是IL-2调节的分子机制提供直接的机械洞察力。提出了新的初步结果,表明AEA和2AG抑制IL-2抑制取决于COX-2代谢导致核受体的激活,过氧化物酶体增殖物激活受体伽马(PPARGAMMA),独立于CB1和CB2。还有其他结果表明,特定机制涉及通过PPARGAMMA激活破坏活化T细胞(NFAT)的核因子。基于上述观察结果和提案中提出的其他初步数据,我们目前的研究将检验假设:内源性大麻素,AEA和2-AG抑制IL-2,通过两个不同的大麻素受体对NFAT调节进行介导 - 非依赖性机制:(a)细胞内钙调节的改变; (b)COX-2介导的AEA和2-AG转化为Ppargamma激动剂后的PPARGAMMA的激活。我们将使用以下特定目的(SA):SA1来检验我们的假设,以表征通过AEA通过AEA和2Ag扮演NFAT的调节而改变的作用,从而改变NFAT的调节,从而抑制IL-2基因表达。 SA2是为了表征Cox-2在NFAT放松管制和通过AEA和2-AG抑制IL-2的作用; SA3是为了表征通过AEA激活PPARGAMMA在NFAT调控和抑制IL-2中激活的作用; SA4旨在识别和表征AEA的生物活性形式和负责PPARGAMMA激活的2-Ag,并阐明其对IL-2抑制的贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Norbert E Kaminski其他文献

Norbert E Kaminski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Norbert E Kaminski', 18)}}的其他基金

Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
  • 批准号:
    10153106
  • 财政年份:
    2021
  • 资助金额:
    $ 29.48万
  • 项目类别:
Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
  • 批准号:
    10647734
  • 财政年份:
    2021
  • 资助金额:
    $ 29.48万
  • 项目类别:
Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
  • 批准号:
    10472461
  • 财政年份:
    2021
  • 资助金额:
    $ 29.48万
  • 项目类别:
IUTOX 15th International Congress of Toxicology
IUTOX 第十五届国际毒理学大会
  • 批准号:
    9804800
  • 财政年份:
    2019
  • 资助金额:
    $ 29.48万
  • 项目类别:
Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses
大麻素调节免疫细胞引发的星形胶质细胞功能,抑制 HIV 相关的神经炎症反应
  • 批准号:
    10619501
  • 财政年份:
    2018
  • 资助金额:
    $ 29.48万
  • 项目类别:
Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses
大麻素调节免疫细胞引发的星形胶质细胞功能,抑制 HIV 相关的神经炎症反应
  • 批准号:
    9920700
  • 财政年份:
    2018
  • 资助金额:
    $ 29.48万
  • 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
  • 批准号:
    8477192
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
  • 批准号:
    8685982
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
  • 批准号:
    8230321
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
  • 批准号:
    8334564
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:

相似海外基金

Development of a Nonpsychotropic Cannabinoid Agonist for the Treatment of Sclerod
开发用于治疗硬化症的非精神药物大麻素激动剂
  • 批准号:
    8353713
  • 财政年份:
    2012
  • 资助金额:
    $ 29.48万
  • 项目类别:
Role of Cyclopentenone prostaglandins in promoting recovery after TBI
环戊烯酮前列腺素在促进 TBI 后恢复中的作用
  • 批准号:
    7870767
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
Role of Cyclopentenone prostaglandins in promoting recovery after TBI
环戊烯酮前列腺素在促进 TBI 后恢复中的作用
  • 批准号:
    8898730
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
Role of Cyclopentenone prostaglandins in promoting recovery after TBI
环戊烯酮前列腺素在促进 TBI 后恢复中的作用
  • 批准号:
    8894329
  • 财政年份:
    2011
  • 资助金额:
    $ 29.48万
  • 项目类别:
PPAR-gamma as a therapeutic target after TBI
PPAR-γ 作为 TBI 后的治疗靶点
  • 批准号:
    7934095
  • 财政年份:
    2009
  • 资助金额:
    $ 29.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了